Matches in SemOpenAlex for { <https://semopenalex.org/work/W2503221281> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2503221281 endingPage "869" @default.
- W2503221281 startingPage "856" @default.
- W2503221281 abstract "1. Quizartinib absorption, metabolism and excretion were characterized in six healthy men receiving a single oral dose of 60 mg (≈100 μCi) of [14C]-quizartinib. Blood, plasma, urine and faeces were collected ≤336 h postdose. 2. Four hours postdose, maximum mean ± SD blood radioactivity concentrations were 296 ± 67.4 ng equivalents/g. A mean ± SD of 1.64 ± 0.482% and 76.3 ± 6.23% of the dose was recovered in urine and faeces, respectively, within 336 h postdose. 3. Radio-detector high-performance liquid chromatography (radio-HPLC) and liquid chromatography-mass spectrometry (LC-MS) showed two main radioactive peaks in plasma, unchanged quizartinib and mono-oxidative metabolite, AC886. Five additional metabolites in plasma were identified by LC-MS, but low levels prevented radio-HPLC detection. Although unchanged quizartinib was the main radioactive component in faeces (mean, 4.0% of administered dose), 15 metabolites representing a mean of 1.0-3.5% of administered dose were found. Quizartinib was predominantly metabolized by phase I biotransformations (oxidation, reduction, dealkylation, deamination, hydrolysis and combinations thereof). 4. This study indicated that quizartinib was rapidly and orally bioavailable, extensively metabolized, with AC886 as the major circulating metabolite, and predominantly eliminated in faeces. Quizartinib was well tolerated in the subjects." @default.
- W2503221281 created "2016-08-23" @default.
- W2503221281 creator A5029114256 @default.
- W2503221281 creator A5029720227 @default.
- W2503221281 creator A5040313726 @default.
- W2503221281 creator A5069079445 @default.
- W2503221281 creator A5069660536 @default.
- W2503221281 creator A5088338818 @default.
- W2503221281 date "2017-07-25" @default.
- W2503221281 modified "2023-10-07" @default.
- W2503221281 title "An open-label, single-dose, phase 1 study of the absorption, metabolism and excretion of quizartinib, a highly selective and potent FLT3 tyrosine kinase inhibitor, in healthy male subjects, for the treatment of acute myeloid leukemia" @default.
- W2503221281 cites W1601736893 @default.
- W2503221281 cites W1988614680 @default.
- W2503221281 cites W1988733714 @default.
- W2503221281 cites W2007044832 @default.
- W2503221281 cites W2011187792 @default.
- W2503221281 cites W2019333269 @default.
- W2503221281 cites W2023568503 @default.
- W2503221281 cites W2034820298 @default.
- W2503221281 cites W2043696829 @default.
- W2503221281 cites W2086039105 @default.
- W2503221281 cites W2129615499 @default.
- W2503221281 cites W2146496405 @default.
- W2503221281 cites W2147338626 @default.
- W2503221281 cites W2153810740 @default.
- W2503221281 cites W2161821474 @default.
- W2503221281 cites W2321946412 @default.
- W2503221281 cites W2503221281 @default.
- W2503221281 doi "https://doi.org/10.1080/00498254.2016.1217100" @default.
- W2503221281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27460866" @default.
- W2503221281 hasPublicationYear "2017" @default.
- W2503221281 type Work @default.
- W2503221281 sameAs 2503221281 @default.
- W2503221281 citedByCount "22" @default.
- W2503221281 countsByYear W25032212812017 @default.
- W2503221281 countsByYear W25032212812018 @default.
- W2503221281 countsByYear W25032212812019 @default.
- W2503221281 countsByYear W25032212812020 @default.
- W2503221281 countsByYear W25032212812021 @default.
- W2503221281 countsByYear W25032212812022 @default.
- W2503221281 countsByYear W25032212812023 @default.
- W2503221281 crossrefType "journal-article" @default.
- W2503221281 hasAuthorship W2503221281A5029114256 @default.
- W2503221281 hasAuthorship W2503221281A5029720227 @default.
- W2503221281 hasAuthorship W2503221281A5040313726 @default.
- W2503221281 hasAuthorship W2503221281A5069079445 @default.
- W2503221281 hasAuthorship W2503221281A5069660536 @default.
- W2503221281 hasAuthorship W2503221281A5088338818 @default.
- W2503221281 hasConcept C10146269 @default.
- W2503221281 hasConcept C112705442 @default.
- W2503221281 hasConcept C151730666 @default.
- W2503221281 hasConcept C179998833 @default.
- W2503221281 hasConcept C185592680 @default.
- W2503221281 hasConcept C2777477808 @default.
- W2503221281 hasConcept C2780026642 @default.
- W2503221281 hasConcept C43617362 @default.
- W2503221281 hasConcept C55493867 @default.
- W2503221281 hasConcept C61716771 @default.
- W2503221281 hasConcept C62231903 @default.
- W2503221281 hasConcept C71924100 @default.
- W2503221281 hasConcept C86803240 @default.
- W2503221281 hasConcept C98274493 @default.
- W2503221281 hasConceptScore W2503221281C10146269 @default.
- W2503221281 hasConceptScore W2503221281C112705442 @default.
- W2503221281 hasConceptScore W2503221281C151730666 @default.
- W2503221281 hasConceptScore W2503221281C179998833 @default.
- W2503221281 hasConceptScore W2503221281C185592680 @default.
- W2503221281 hasConceptScore W2503221281C2777477808 @default.
- W2503221281 hasConceptScore W2503221281C2780026642 @default.
- W2503221281 hasConceptScore W2503221281C43617362 @default.
- W2503221281 hasConceptScore W2503221281C55493867 @default.
- W2503221281 hasConceptScore W2503221281C61716771 @default.
- W2503221281 hasConceptScore W2503221281C62231903 @default.
- W2503221281 hasConceptScore W2503221281C71924100 @default.
- W2503221281 hasConceptScore W2503221281C86803240 @default.
- W2503221281 hasConceptScore W2503221281C98274493 @default.
- W2503221281 hasIssue "10" @default.
- W2503221281 hasLocation W25032212811 @default.
- W2503221281 hasLocation W25032212812 @default.
- W2503221281 hasOpenAccess W2503221281 @default.
- W2503221281 hasPrimaryLocation W25032212811 @default.
- W2503221281 hasRelatedWork W118183763 @default.
- W2503221281 hasRelatedWork W1970888742 @default.
- W2503221281 hasRelatedWork W2008727242 @default.
- W2503221281 hasRelatedWork W2045937169 @default.
- W2503221281 hasRelatedWork W2046827994 @default.
- W2503221281 hasRelatedWork W2081993762 @default.
- W2503221281 hasRelatedWork W2198402314 @default.
- W2503221281 hasRelatedWork W2377630970 @default.
- W2503221281 hasRelatedWork W2406364491 @default.
- W2503221281 hasRelatedWork W2409773942 @default.
- W2503221281 hasVolume "47" @default.
- W2503221281 isParatext "false" @default.
- W2503221281 isRetracted "false" @default.
- W2503221281 magId "2503221281" @default.
- W2503221281 workType "article" @default.